from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3505/fadE27

LFCtreatmentdescriptionclass of inhibitor

1.325

Amikacinug/mL Amikacintranslation

0.772

Cap5-10ug/mL Capreomycintranslation

1.498

Rox10-50 ug/mL Roxithromycintranslation

0.958

SM2-5 ug/mL Streptomycintranslation

1.511

Tet5-10 ug/mL Tetracyclinetranslation

-0.575

Rif0.2-5ug/mL Rifampicintranscription

0.158

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.240

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.110

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.632

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.238

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.488

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.572

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.806

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.714

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.223

Econazole10-24 ug/mL Econazole (azole drug)respiration

-3.019

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.040

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.225

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.541

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.101

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.278

Nigericin50 uM Nigericinrespiration

-0.401

TRC10-150 ug/mL Triclosanrespiration

-1.756

TRZ10-25 ug/mL Thioridazinerespiration

0.596

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.519

menadione6-10 ug/mL Menadionerespiration

2.481

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.165

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.362

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.750

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.412

NRP_1Non-replicating persistence stage 1dosRassociated

0.091

Amp0.2mg/mL AmpicillincellWall

-0.278

Cephalexin20-100 ug/mL CephalexincellWall

-0.206

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.705

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.147

EMB10-20 ug/mL EthambutolcellWall

0.221

Eta12-40 ug/mL EthionamidecellWall

0.159

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.236

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.888

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.950

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.759

BZA0.12 mg/mL BenzamidearomaticAmides

0.328

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.633

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.544

H2O24 mM hydrogen peroxideDNAdamaging

0.321

Levo10 ug/mL LevofloxacinDNAdamaging

-0.051

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.999

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.158

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.817

UVUV-irradiationDNAdamaging

0.475

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.167

Antimycin12.5-50 ug/mL Antimycin A?

-0.336

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.857

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.672

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.356

PA8240.2-2 ug/mL PA-824?

0.827

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.142

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.921

Verapamil50 uM Verapamil?

-0.620

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.881

methoxatin10-20 ug/mL Methoxatin?